LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. The firm designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
Follow-Up Questions
¿Cuál es el ratio P/E de LivaNova PLC (LIVN)?
El ratio P/E de LivaNova PLC es 46.3946
¿Quién es el CEO de LivaNova PLC?
Mr. Vladimir Makatsaria es el Chief Executive Officer de LivaNova PLC, se unió a la empresa desde 2024.
¿Qué tal es el rendimiento del precio de la acción LIVN?
El precio actual de LIVN es de $54, ha increased un 0.5% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de LivaNova PLC?
LivaNova PLC pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de LivaNova PLC?
La capitalización bursátil actual de LivaNova PLC es $2.9B
¿Es LivaNova PLC una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 12 analistas han realizado calificaciones de análisis para LivaNova PLC, incluyendo 6 fuerte compra, 7 compra, 3 mantener, 0 venta, y 6 fuerte venta
